National Center for Biotechnology Information

News and Video Search Results

News coverage

Global Times: China-Serbia ironclad friendship sets a role model in the new era: Chinese Ambassador to Serbia Li Ming

PR Newswire Asia 08 May 2024

BEIJING, May 8, 2024 /PRNewswire/ -- China and Serbia have long been renowned for their ironclad friendship. The bond between the..

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GoodRx, Autodesk, Global Cord, and Lincoln and Encourages Investors to Contact the Firm
GlobeNewswire 08 May 2024
Gynecology Collaboration, R&D, and Licensing Deals Trends Report 2024
GlobeNewswire 07 May 2024
Stem Cell Collaboration, R&D, and Licensing Deals Analysis Report 2024 with Directory of 162 Agreements Signed Since 2016
GlobeNewswire 07 May 2024
Antibiotic Collaboration and Licensing Deals Analysis Report 2024 with Directory of 133 Agreements Signed Since 2019
GlobeNewswire 07 May 2024

0 shares 1 views

You might like

National Center for Biotechnology Information media coverage

599 Cancer Monoclonal Antibody Collaboration and Licensing Deals Report and Directory 2016-2024

GlobeNewswire 07 May 2024

Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2024" report has..

Vect-Horus to Take Part in a Roundtable Discussion at Viva Technology Conference
GlobeNewswire 07 May 2024
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024
GlobeNewswire 06 May 2024
Retinitis Pigmentosa Market Size Expected to Reach USD 21.40 Bn by 2033
GlobeNewswire 06 May 2024
Immunic to Participate in Investor and Scientific Conferences in May
EQS Group 06 May 2024

Advertisement

More coverage

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Doximity, Global Cord, and Lincoln Innovations and Encourages Investors to Contact the Firm

GlobeNewswire 04 May 2024

NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm,..

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID)
GlobeNewswire 30 Apr 2024
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
GlobeNewswire 29 Apr 2024
Innovations in Cardiac Care: The Future of Cardiac Ablation Devices Revealed
GlobeNewswire 29 Apr 2024
ProteoGenix and Cizzle Biotechnology Collaboration Forges New Paths in Early Detection of Lung Cancer through Innovative Antibody Development
Pressat 29 Apr 2024